An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Consideration for Use of Novel Agents in Acute Myeloid Leukemia 0.55 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Optimizing the Care of Patients Receiving CAR T-Cell Therapy 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Emerging Options for the Management of Relapsed/Refractory Hodgkin Lymphoma 0.54 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms 0.75 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Keynote Session: CAR T-cell Therapy - Historical Perspectives and Major Milestones 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Patient Case Studies and Panel Discussion: Lymphoma 1.00 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Patient Case Studies and Panel Discussion: Leukemia and Myeloproliferative Neoplasms 1.00 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Management of Toxicities Associated with Immune Checkpoint Inhibitors 0.40 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Optimizing Small Molecule Inhibitor Therapy for Relapsed/Refractory B-cell Lymphomas 1.00 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Current Approaches to Initial Treatment of Newly Diagnosed Multiple Myeloma 0.52 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Keynote Session: CAR T-cell Therapy - Focus on Lymphomas 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Updates in the Management of CLL: Histologic Transformation and Relapsed/Refractory Disease 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Optimizing TKI Therapy for Chronic Phase CML: Sequencing of TKI Therapy and Treatment-free Remission 0.54 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Strategies to Identify Needs and Coordinate Referrals to a Multidisciplinary Chronic Graft-Versus-Host Disease Clinic 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am
Emerging Options and Sequencing Therapies for Relapsed Multiple Myeloma 0.50 11/01/2018 - 12:00am to 11/01/2019 - 12:00am

Pages